NEWS

 

February 17th, 2020

The creation of a Unified Cancer Centre is under discussion in Brussels

The first joint meeting of the EC Cancer Mission Council and the Assembly of this mission took place in Brussels, 14 February, to discuss actions to be taken in the strategic planning documents.

Members of the Assembly, leaders and members of many of the leading European organizations in the field of oncology, had prepared a number of recommendations and additions to the documents produced by the Mission Council.

Activities include many potential issues for Latvia, such as the establishment and accreditation of a national Unified Cancer Center (currently one of the six EU countries where such accreditation does not exist), ensuring the availability of a cancer screening system that meets European quality criteria, etc.

As an unprecedented negative example of the EU, all participants of the meeting were publicly referred to the Latvian-Estonian alcohol tax fight.

February 14th, 2020

Latvia joins network of European infrastructure for translational medicine

From 11 to 12 February, the annual meeting of the EATRIS European infrastructure for translational medicine Course was held in Lisbon, Portugal.

Since the beginning of 2020, Latvia has joined the network as an associate member.

During these two days, was exchange best practices and defined together the role that EATRIS will play in the development of Personalised Medicine. Also were discused how to fully exploit the capacities of the Infrastructure to serve the needs of the patient community and how to develop technologies that will support the implementation of patient-targeted interventions.

In the picture (from left): Latvian delegation - Zaiga Nora-Krūkle, Ilmārs Stonāns, Maija Dambrova, Mārcis Leja

February 7th, 2020

At the conference in St. Petersburg reports on the epidemiology of stomach cancer and screening options

On February 6, a scientific-practical conference on the different aspects of gastric cancer "Stomach Cancer - A to Z" was held at Pavlov First Saint Petersburg State Medical University. The conference was attended by leading oncologists and management from St. Petersburg University, and practitioners from hospitals and outpatient clinics in the region.

The keynote presentation of the conference on the epidemiology and screening capabilities of gastric cancer was given by director of KPMI, professor M.Leja. 

In his lecture, he focused on both the GISTAR project implemented by the International Agency for Research on Cancer and the diagnostic capabilities of volatile markers, including those currently underway in the H2020 VOGAS project.

  

In the picture: M.Leja with the main organizer of the conference, oncology surgeon, Professor Alexander Zakarenko

VOGAS project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824986 

The GISTAR study is partly funded by the ERDF (European Regional Development Fund) 1.1.1.1. project "Practical Studies", 2nd phase, project ID Nr. 1.1.1.1/18/A/184 "Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention" and FLPP (Fundamental and Applied Research Projects) within the framework of the Latvian Program, project no. lzp-2018 / 1-0135 "Study on the implementation of a set of measures to prevent gastric cancer mortality by eradicating H.pylori infection and timely detection of gastric pre-cancer conditions".

February 4th, 2020

Brussels opens consultation on Europe cancer plan

On February 4, during the World Cancer Day in Brussels, the European Commissioner for Health formally opened a public consultation on Europe's beating cancer plan in the presence of the EC President.

Details can be found HERE

January 30th, 2020

A working meeting for the VOGAS project takes place in Austria

The annual H2020 VOGAS project working meeting takes place in See, Austria, January 26 - 31. During the meeting project progress and future project plans are discussed.

From KPMI the meeting is represented by Director of the institute prof. Mārcis Leja and PhD student Linda Mežmale.

VOGAS project - "Screening of Gastric Cancer via Breath volatile organic compunds by Hybrid Sensing Approach".

The aim of the VOGAS H2020 project is to clarify the sources of volatile markers, to perform the clinical approbation of the latest generation stationary breath analyzer for early diagnosis of cancer. Using the latest generation of stationary breath analyzers to detect volatile markers, take part in an international stomach cancer screening program to improve this non-invasive method of for diagnosis of cancer.

 

The project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824986 

January 28th, 2020

Invites to a seminar on actual ethical and social problems of research biobank governance in the Baltic states as part of the annual Scientific Conference of the University of Latvia

We kindly invite experts and representatives of research biobanks to attend an international workshop “Ethically and socially responsible governance of research biobanks in the Baltic states” which will take place on March 19, 2020 at the University of Latvia. The aim of the workshop is to exchange experience and discuss actual ethical and social problems of research biobank governance in the Baltic states, as well as to present the results of the project “Ethically and socially responsible governance of research biobanks in Latvia: analysis of opinions of public, donors and researchers”, this project is funded by the Latvian Council of Science, project No. lzp-2018/2-01710. The co-organizer of the workshop is BBMRI-ERIC (Biobanking and Biomolecular Resources Research Infrastructure – European Research Infrastructure Consortium).  

All participants are welcome to register to the workshop via email kpmi@lu.lv by March 1, 2020. Registration is free of charge, on a first-come, first-served basis.

The preliminary programme of the workshop you can find HERE.

The workshop will be part of the annual 78th Scientific Conference of the University of Latvia. You are also kindly invited to submit an abstract and to participate in the conference on March 20, 2020.

https://www.mf.lu.lv/petnieciba/konferences/international-scientific-conference-on-medicine/

The work was supported by FLPP (Fundamental and Applied Research Projects) Programm in Latvia, project nr. lzp-2018/2-0171 "Ethically and socially responsible governance of research biobanks in Latvia: analysis of opinions of public, donors and researchers"

January 24th, 2020

New EU Beating Cancer Plan outlined in Brussels Oncology Meeting

A joint meeting of the "Horizon 2020" Programme Committee and Steering Group on Health Promotion, Disease Prevention and Management of Non-Communicable Diseases is taking place today in the European Commission building in Brussels. During the session was analyzed the survey of resources invested in cancer research by EU Member States, outlined the new EU Beating Cancer Plan and gaved a brief overview of the activities of the EU Cancer Mission. At the meeting Latvia is represented by the Ministry of Health and Education, the National Agency for Education and Development, as well as members of the Program Committee, including director of KPMI M.Leja. 

January 23th, 2020

Invites to apply for train the trainer program  in research ethics and academic integrity

As a consortium partner of H2020 VIRT2UE project providing a methodologically sound and didactically innovative train the trainer program for ethics and research integrity trainers, the Institute of Clinical and Preventive Medicine, University of Latvia is organizing the regional training. The face-to-face training will take place on June15-16 and August 28, 2020 (2+1 days) in Riga, University of Latvia.  
Using a virtue ethics approach to ethics and research integrity, the program aims to foster the internalization of the principles of European Code of Conduct for Research Integrity (ECoC), and thus to facilitate the cultivation of scientific virtues among trainers and researchers. 
The program consists of an online module and three days of face to face training. Further information on its content and structure can be found in a brochure on the Embassy of Good Science available under www.embassy.science/training.  
You can register for the train the trainer programme by sending a filled registration form to the e-mail kpmi@lu.lv by April 1, 2020. 

   

The work was supported by  funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 787580

January 20th, 2020

Within the framework of the H2020 project learns a method for faster, more accessible and easier diagnosis of tuberculosis and other diseases

January 14 - 16, KPMI researchers Ilva Pole, Reinis Vangravs and Ģirts Šķenders visited Munich to learn the ultra-fast polymerase chain reaction method for faster, more accessible and easier diagnosis of tuberculosis and potentially other diseases. The basic principles of the method have been developed at the partner GNA Biosolutions Laboratory, within the framework of Horizon 2020 project "Point-of-Care implementation of TB testing with ultrafast laser PCR" (PITBUL). The task of the Latvian researchers in this project is to improve the principles of clinical specimen preparation for further use in the ultrafast polymerase chain reaction method.

  

The project leading to this application has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 768889

January 13th, 2020

9,000 respondents already in GISTAR study!

We are pleased to announce that the total number of respondents included in GISTAR, the largest LU KPMI study, has already reached 9,000!

In its turn, Jekabpils Regional Center has already included 689 respondents.

It is planned to continue the research in Jekabpils till the end of this year.

The GISTAR study in Latvia has been going on for six years.

  

The GISTAR study is partly funded by the ERDF (European Regional Development Fund) 1.1.1.1. project "Practical Studies", 2nd phase, project ID Nr. 1.1.1.1/18/A/184 "Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention" and FLPP (Fundamental and Applied Research Projects) within the framework of the Latvian Program, project no. lzp-2018 / 1-0135 "Study on the implementation of a set of measures to prevent gastric cancer mortality by eradicating H.pylori infection and timely detection of gastric pre-cancer conditions".

January 10th, 2020

One of the initiators of the Million Microbiome of Human Project (MMHP) - LU KPMI

January 6-8, 2020, Shenzhen, China.  The 1st Symposium on Million Microbiome of Human Project (MMHP) took place in the China National GeneBank. This is an ambitious and unique project aiming to draw human microbial maps of different races, ages, genders and health conditions based on at least 1 milj. metagenome analysis.
Involvement of research institutions from all over the world is anticipated. Latvia has been among the initiators of the project. The Director of the Latvian Biomedical Research and Study Centre Jānis Kloviņš and the Director of Institute of Clinical and Preventive Medicine Mārcis Leja were representing our country in the conference. They were presenting the research performed in this field in Latvia so far.
MMHP is supported by the internationally leading experts in molecular biology – the BGI Company. Their daughter company MGI is also established in Latvia.

January 7th, 2020

PERSIST : AI and Big Data available to healthcare 

Lead by Gradiant, Spanish ICT technology center in collaboration with the University of Latvia and eleven other partners, PERSIST is starting in January 2020. 

The PERSIST project will combine the expertise of its partners to develop an innovative platform that will support the decision-making of medical doctors to improve the care of cancer survivors.

13 entities from 10 countries participate in this international research based on Artificial Intelligence and Big Data for the health industry.

The consortium, with partners from Spain, Italy, Austria, Bulgaria, Slovenia, Latvia, Switzerland, Portugal, Belgium and Turkey, is funded by the European Union with more than 5 million euros, under the Horizon 2020 program. 

Within the framework of the PERSIST project, Institute of Clinical and Preventive Medicine of the University of Latvia will provide clinical research.

More information about the PERSIST project see HERE.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 875406

January 6th, 2020

Visits China National Gene Bank

Marcis Leja, Director of KPMI, together with Janis Klovins, Director of the Latvian Biomedical Research and Study Center / BBMRI Latvian Organization, visits to the CNGB - the China National Gene Bank.

08.01.2020. Shenzhen (China). Wang Jian, the president and founder of BGI, demonstrates sequencing automation capabilities at China's National Biobank.

 

December 20th, 2019

Season's greetings and a Happy New Year!

December 17th, 2019

Congratulations to the staff of our institute on the gratitudes of the Rector!

Yesterday a meeting was held at the University of Latvia Faculty of Medicine.
During the meeting, the Rector's gratitudes were also presented.
Acknowledgments of significant achievements, contributions and the 100th anniversary of the University of Latvia were presented to the following employees of the Institute:

Mg.env.sc. Līga Grantiņa, Senior Expert of the Institute of Clinical and Preventive Medicine, ., for her enthusiasm, initiative and tremendous contribution to the establishment of the Institute of Clinical and Preventive Medicine at the University of Latvia during her term as Executive Director.

Dr.sc.ing. Arnis Kiršners, Leading Researcher, Institute of Clinical and Preventive Medicine,, For his significant contribution to the development of the KPMI Biobank IT Platform.

Dr.sc.soc. Signe Mežinska, Senior Researcher, Institute of Clinical and Preventive Medicine, on the development of ethics research at the University of Latvia, on professional ethics advice for other researchers.

Dr.sc.ing. Inese Poļaka, a senior researcher at the Institute of Clinical and Preventive Medicine, an ERDF postdoctoral fellow, for her significant support in student research design and data analysis, for her outstanding performance as a GISTAR research statistician.

Aiga Rudūle, Senior Expert, Institute of Clinical and Preventive Medicine, for successful administrative management of the GISTAR study.

Dr.med. Daiga Šantare, associate professor at Department of Oncology, Faculty of Medicine. 

Congratulations!

In the picture: Aiga Rūdule, Administrative Manager of the GISTAR study, with a letter of gratitude

December 13th, 2019

Representatives of Latvia are not applied for the activities of the European Cancer Mission

The second meeting of the Cancer Mission set up by the European Commission with representatives of EU Member States takes place in Brussels. Two representatives from each Member State are invited to familiarize themselves with the work of the Cancer Mission, to organize it in the interest of the Member States, and to make recommendations for joint European action on the development of national cancer programs.
Almost all EU Member States are represented at the meeting (with rare exceptions - Latvia).
The representatives of Latvia are not applied for this strategic meeting, neither for the aforementioned joint European activity.

December 5th, 2019

Prof. Marcis Leja: Cancer is provoked by a good quality of life

In early September, the Council of the European Cancer Mission gathered in Brussels for the first meeting, where Latvia is represented by Marcis Leja, a professor at the University of Latvia (LU) and director of the Institute of Clinical and Preventive Medicine of the LU. The purpose of the Council is to put into practice and apply scientific discoveries and to explain them to the general public.

Professor Marcis Leja was invited by Iveta Sazonova, editor of the Communication and Innovation Department, University of Latvia, to discuss cancer research, new technologies and the situation in Latvia.

For the full interview, read:

https://www.lu.lv/par-mums/lu-mediji/zinas/zina/t/55876/

December 3rd, 2019

More than 500 participants have already applied for the GISTAR study in Jekabpils

We are proud to announce that the total number of respondents included in the GISTAR (largest study of LU KPMI) Jekabpils Regional Research Center has reached 500 respondents. The total number of respondents included in the survey has reached already 8 880!

Correspondent of the newspaper "Brīvā Daugava" Inese Zone invited Olga Kirejeva, the 500th respondent, to talk about the opportunities provided by the survey.

The GISTAR study in Latvia has been going on for six years. Jekabpils Regional Research Center, in its turn, has been operating since September 2019. The realization of the study in Jekabpils is currently planned until the end of 2020. In parallel, the feasibility of the study in other Latvian cities is being discussed.

Read the article and interview HERE

In the picture: Doctor's assistant Sendija Vītola (from left) and 500th respondent Olga Kirejeva

The GISTAR study is partly funded by the ERDF (European Regional Development Fund) 1.1.1.1. project "Practical Studies", 2nd phase, project ID Nr. 1.1.1.1/18/A/184 "Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention" and FLPP (Fundamental and Applied Research Projects) within the framework of the Latvian Program, project no. lzp-2018 / 1-0135 "Study on the implementation of a set of measures to prevent gastric cancer mortality by eradicating H.pylori infection and timely detection of gastric pre-cancer conditions".

November 28th, 2019

Receives an award for the best stand report at the International Genetics Conference

On November 25 - 26, "International Conference on Genomics & Pharmacogenomics" and "International Conference on Human Genetics and Genetic Disorders" took place in Madrid, Spain. Dārta Pūpola, scientific assistant at the LU KPMI presented the main results of the ERDF project "Long term effects of H.pylori eradication on Gastro intestinal tract microbiome and development of screening system for detection of extended-spectrum beta-lactamase coding genes within feces samples".

D.Pūpola received an award for her report as the best stand presentation at the conference.

Results were obtained by analyzing samples from respondents included in the largest study of KPMI - GISTAR.

The project “Long term effects of H.pylori eradication on Gastro intestinal tract microbiome and development of screening system for detection of extended-spectrum beta-lactamase coding genes within feces samples” has received funding from ERDF (European Regional Development Fund) program under the grant agreement no. 1.1.1.1./16/A/272

November 19th, 2019

Receives the award for Best Presentation at the European Bridging Meeting in Gastroenterology

European Association for Gastroenterology, Endoscopy and Nutrition (EAGEN) on November 15-16 in Warsaw, Poland held The European Bridging Meeting in Gastroenterology 2019 to enable young researchers to present their work in the presence of their scientific supervisors. Each participant was accompanied by a mentor who, after the presentation, led a discussion on different aspects of the work. During the scientific meeting 42 young researchers presented their work. After the conference, the Scientific Commission awarded 5 top-rated presentations.

From Latvia conference was attended by Danute Ražuka-Ebela (resident in gastroenterology, PhD candidate of the University of Latvia) with her supervisor prof. Mārcis Leja. Danute received the award for Best Presentation for her report "Analysis of factors associated with decreased pepsinogen in the GISTAR study population in Latvia".

The initiative started in 1998 by Prof. Dr. Peter Malfertheiner in Magdeburg, Germany. His vision and aim when he designed the Bridging Meeting concept was to create a forum for young clinical investigators from Eastern and Western European countries, where results of their ongoing and completed research is presented. To allow for young Fellows, academic teachers & mentors and industry partners to meet, network, build bridges and build a path into the Future of Gastroenterology.

More information about meeting HERE.

In the picture from left: Chair of the Scientific Committee of the Conference Prof. Jaroslaw Regula and Prof. Peter Malfertheiner, Danute Ražuka-Ebela, Prof. Mārcis Leja

The GISTAR study is partly funded by the ERDF (European Regional Development Fund) 1.1.1.1. project "Practical Studies", 2nd phase, project ID Nr. 1.1.1.1/18/A/184 "Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention" and FLPP (Fundamental and Applied Research Projects) within the framework of the Latvian Program, project no. lzp-2018 / 1-0135 "Study on the implementation of a set of measures to prevent gastric cancer mortality by eradicating H.pylori infection and timely detection of gastric pre-cancer conditions".

November 14th, 2019

Gratitude to M.Leja for his contribution to the "EU - Together we protect" campaign

In 2019, the European Commission ran an EU-wide information campaign "#EU - Together we protect". The campaign aimed to raise public awareness of the various aspects of security and show what different professions do on a daily basis to make our lives in Latvia and Europe safer.

Thanks to the responsiveness and participation of the campaign's envoys, the Latvian population has become familiar with the work of many professionals in the fields of creating a safer environment for the Internet, food and household safety controls, nature protection, safe travel and combating human trafficking. The campaign has made the name of Latvia more widely known, giving people of other EU countries the opportunity to learn about what has been done in Latvia.

Director of our institute Marcis Leja has received GRATITUDE for his contribution to this campaign.

CONGRATULATIONS!

More information on the campaign website.

November 13th, 2019

Call for Applications round 2020 for NORDPLUS projects

Applications for the NORDPLUS sub-programs Youth Education, Higher Education, Adult Education, Horizontal Program, Nordic Languages may be submitted through the Espresso electronic system by February 3, 2020.

More information on the competition is available on the website of the National Agency for Education Development.

On November 20, from 10 am to 3:30 pm in the hotel "Avalon" (13. Janvāra Street 19, Riga) an information seminar "Terms and conditions of Nordplus program competition 2020" will take place.
More information about the seminar- HERE

Apply for the seminar online by November 14th.

  

November 8th, 2019

Takes place Conference on implementation of Horizon Europe program in Latvia

On November 7-8 this year, the Ministry of Education and Science, together with the European Commission's Directorate-General for Science and Innovation, is organizing a conference "Towards Horizon Europe Implementation in Latvia".

The conference was opened by President of Latvia Egils Levits.

The responsible bodies of the European Commission are also represented at the highest level, with the Brussels delegation headed by Jean-Eric Paquet, Director-General of DG Reaserch & Innovation.

The conference discussed the expected changes in the organization of various research-related programs. Particular attention is paid to expansion programs, i.e. special support programs for countries with less successful track record (including Latvia). Success stories presented. Suggestions for project preparation are provided. Last year was the first time Latvia received more from the EU in the form of successfully funded projects than the state paid into the program.

Even in smaller working groups, Jean-Eric Paquet got acquainted with the views of the responsible institutions on Latvia's future needs.

Marcis Leja presented the work of the Cancer Mission of Europe Union. 

  

November 1th, 2019

Data from the GISTAR study in Kazakhstan are presented at a conference in Astana

The 14th International Scientific-Practical Conference “Astana-Gastro-2019” is taking place in Nur-Sultan (Kazakhstan).
A presentation “Gastric Cancer Screening. GISTAR study ”at the conference was presented by M. Leja.
The presentation also showcased the results of the work done by the researchers of the LU KPMI, which was obtained by analyzing the material obtained in Kazakhstan.

The GISTAR study is partly funded by the ERDF (European Regional Development Fund) 1.1.1.1. project "Practical Studies", 2nd phase, project ID Nr. 1.1.1.1/18/A/184 "Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention" and FLPP (Fundamental and Applied Research Projects) within the framework of the Latvian Program, project no. lzp-2018 / 1-0135 "Study on the implementation of a set of measures to prevent gastric cancer mortality by eradicating H.pylori infection and timely detection of gastric pre-cancer conditions".

October 30th, 2019

Invites to the seminar “Biobanks – sustainable resource for improvement of public health”

Latvian Biomedical Research and study centre invites to participate in seminar that is organized by Latvian national biobank network – BBMRILV.
In this seminar leading researchers from largest research organizations in Latvia will share their experience how to ensure sustainable research of human biological materials. The general situation in Latvia, creation of large national level research projects, how to research maximal quality in most cost effective manner, as well as ethical and social implications will be discussed.
Time: November 11th, 2019, 9.00 - 11.30

Place: Riga, University of Latvia, Faculty of Natural Sciences, auditorium 702 (7th floor), Jelgavas Str. 1.

Program (in Latvian) HERE 

Registration for the seminar here HERE

   

The organization of the seminar is supported by ERDF project No. 1.1.1.5/18/I/006 “Support for the integration of the Latvian Biomedical Research and Study Centre into the European Research Area and Infrastructure objects”

October 29th, 2019

The article looks at the contradiction between the recommendations of gastroenterologists and the strategy for limiting antibiotic use

The USA magazine Digestive Diseases and Sciences today published an article in its online version by M. Leja (doctor - gastroenterologist, professor) and U. Dumpis (doctor infectologist, professor) "What Would the Screen-and-Treat Strategy for Helicobacter pylori Mean in Terms of Antibiotic Consumption?". The article talks about the controversy surrounding the recommendations of gastroenterologists and the strategy to limit the use of antibiotics. The analysis was performed using antibiotic consumption data in Latvia.

 A summary of an article is available HERE.

 

October 25th, 2019

In Brussels welcomes the work done on the H2020 project A-PATCH 

On 24 October a reporting event for the European Commission for the 1st period of the Horizon 2020 project A-PATCH (Autonomous Patch for Real-Time Detection of Infectious Disease) was held in Brussels.
Scientific officer at European Commission Henri Rajbenbach and external evaluator Stephan Kirchmeyer took note of the project partners' report and welcomed the work done so far. LU KPMI at the event was represented by researcher Ģirts Šķenders.

On 25 October in Leuven, A-PATCH project partners met IMEC (www.imec-int.com), a design specialist for wearable electronic devices, to discuss technical issues and possible solutions for the new diagnostic approach. This project brings together researchers from various fields of technology from BioRad Laboratories (Israel), TNO HOLST Center (Netherlands), IMEC (Belgium), LU KPMI, CEVA RivieraWaves (France, Ireland, Israel), VTT (Finnish Center for Technical Research) and FIND (Switzerland).

   

 Project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824270

October 24th, 2019

A working meeting for the VOGAS project takes place in Germany

On October 24 - 25 a working meeting of the H2020 project VOGAS is held at Ulm University in Germany.
During the meeting both technological development issues and planned clinical trials in European and Latin American countries are discussed.

These clinical trials are coordinated by LU KPMI.

LU KPMI at the meeting is represented  by VOGAS project expert Linda Mežmale.

   

 Project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824986 

October 21st, 2019

Results of the GISTAR study presented at the UEGW Congress in Barcelona

At the United European Gastroenterology Week in Barcelona, LU KPMI Director M. Leja presented an overview of the world population-based studies for the prevention of gastric cancer. One of the most important researches of such type in the world and the only one in Europe is the GISTAR study carried out in Latvia by the Institute of Clinical and Preventive Medicine of the University of Latvia.

At the congress M. Leja also presented  oral and poster presentations of the young researchers of the LU KPMI - "H. pylori and older age are more related to reduced pepsinogen levels" (first author J. Aleksejeva), and "H. pylori positivity assessed by molecular - biology methods in gastric biopsy samples in serology and histology discrepant cases "(first author S. Skrebinska).

     

The GISTAR study is partly funded by the ERDF (European Regional Development Fund) 1.1.1.1. project "Practical Studies", 2nd phase, project ID Nr. 1.1.1.1/18/A/184 "Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention" and FLPP (Fundamental and Applied Research Projects) within the framework of the Latvian Program, project no. lzp-2018 / 1-0135 "Study on the implementation of a set of measures to prevent gastric cancer mortality by eradicating H.pylori infection and timely detection of gastric pre-cancer conditions".

October 20th, 2019

 At courses young researchers acquire medical articles writing skills 

European Association for Gastroenterology, Endoscopy and Nutrition (EAGEN) in cooperation with French pharmaceutical company Biocodex, organized a course for young researchers on "Medical writing and publishing" on 20 October in Barcelona, ​​Spain. Course were attended by LU KMPI representatives Linda Mežmale, Olga Sjomina, Zane Dzērve and Anna Krīgere. The course was moderated by Amy Whereat (Australia), who specializes as a communications consultant in medical research.

The courses covered topics such as - writing articles - choosing the right journal and giving advice to authors; writing an article - correct sentence formation and thesis structure; formation of introduction, methods, results and discussion - the most important aspects; article submission - effective proofreading and pre-submission conditions. During the courses, participants not only learned the basics of theory but also actively participated in discussions and participated in group work.

  

October 19th, 2019

Invites to a conference dedicated to the next European Union research and innovation program - Horizon Europe

On November 7 - 8, invites to participate in the conference "Towards Horizon Europe Implementation in Latvia", dedicated to the next European Union (EU) research and innovation program Horizon Europe.
The conference will bring together high-level professionals, policy makers, leaders of scientific institutions, scientists and other interested parties.
The event will be opened by the President of Latvia Egils Levits and the leadership of the Ministry of Education and Science.
The concept of Horizon for Europe will be presented by Jean-Eric Paquet, Director-General of the European Commission for Research and Innovation.
On the first day of the conference, Latvia's achievements in the EU research and innovation program Horizon 2020 will be discussed.
On the second day of the conference, it will be possible to find out about the current Horizon Europe program, as well as the conditions for developing and implementing projects from the European Commission.
The event is organized by the Ministry of Education and Science and the National Agency for Education Development.

Participation in the event is free, with pre-registration online until November 1st.

The English version of the program to be updated is available HERE.
Working language: English and Latvian // Place: University of Latvia, House of Science, Alfa, Jelgavas street 3, Riga.

October 18th, 2019

At the WEO annual meeting discusses the quality of screening for colorectal cancer worldwide

Not only political demonstrations but also World Endoscopy Organization Colorectal Cancer (CRC) Screening Committee (SC) meeting are held in Barcelona. Latvia is represented at the meeting by M.Leja and I.Tolmanis.

The purpose of the meeting is to improve the quality of screening for colorectal cancer worldwide. Special attention is paid to the quality of colonoscopy and standardization of screening tests.

At the meeting M.Leja reported data obtained by Anna Krigere, a researcher at the LU KPMI, on the current status of colorectal cancer screening programs in European countries outside the European Economic Area, as well as programs and pilot studies in Russia. Former Latvian gastroenterologist Aldis Kaufmanis, in his capacity as Director of the French Regional Screening Program, reported on the results of the screening program in the region under his supervision.

  

October 16th, 2019

Published Mission - oriented policy for Horizon Europe

The Mission-oriented policy for Commission's forthcoming science program Horizon Europe is published on the European Commission's website.

This is an approach to policy-making which means setting defined goals, with specific targets and working to achieve them in a set time

More information see HERE.

October 15th, 2019

Invites to submit abstract to the 30th ECCMID congress

30th European Congress of Clinical Microbiology & Infectious Diseases, which will take place in Paris, France, 18 - 21 April 2020. ECCMID, as the world’s premier Clinical Microbiology & Infectious Diseases event, brings together experts from many fields to present their latest findings, guidelines and experiences to an audience of over 13,000 colleagues. This year, the Programme Committee has developed a multi-faceted program incorporating keynote lectures and oral sessions, as well as interactive workshops, meet-the-expert sessions, open forums, and a wide range of symposia.

The congress is organized by European Society of Clinical Microbiology and Infectious Diseases. The mission of ESCMID to improve the diagnosis, treatment and prevention of infectious diseases. 

In order to submit your abstract(s) for ECCMID 2020 please follow this link.

October 8th, 2019

At European Biobank Week Congress presents survey results on Latvian population's attitude towards biobanks

From October 8 to 12, Signe Mežinska and Daiga Šantare, researchers at the Institute of Clinical and Preventive Medicine of the University of Latvia, will participate in the European Biobank Week Congress in Lübeck. Researchers will present the results of a representative survey of Latvian residents on their attitude towards biobanks within the framework of the project “Ethically and socially responsible governance of research biobanks in Latvia: analysis of opinions of public, donors and researchers”.

Research biobanks are collections of human biological samples (eg, blood, tissue, urine, respiratory samples). In biobanks, with the consent of the donors, both biological samples and information (eg, age, disease, test results) on the people who donated these samples are stored. With the permission of the Ethics Committee, scientists can analyze samples and related information in specific studies. Biobank scientists are needed to conduct research relevant to public health, diagnosis and treatment of disease. However, the operation of biobanks also raises many ethical questions about how to obtain the informed consent of each biological donor, for what studies to give samples from biobank, how to inform the public about the results of research, etc.

The results of the survey show that the population of Latvia is still poorly informed about research biobanks - only 26% have so far heard about biobanks. 37% of respondents said they would like to provide information about themselves for inclusion in a biobank, which is slightly more than in 2010, when the same questions were asked in the Eurobarometer survey. When asked whether personal data and biological samples should be facilitated between biobanks in the Member States of the European Union, 60% of respondents answered in the affirmative.

The importance of biobanks in carrying out research relevant to public health is growing rapidly, so it is important for citizens to be aware of biobanks, how they work and how to become biobanks donors. Currently, the Law on Biobanks is being developed in Latvia, which requires dialogue between scientists, the public, donors and policy makers. The experience of other countries suggests that the management of biobanks should be based on public opinion research, which significantly contributes to public confidence in biobanks. The research carried out within the framework of the project will provide the currently missing data on public, donor and scientific opinion in the field of biobanks to substantiate the public interest model of biobanks in Latvia, as well as to develop the necessary regulatory enactments.

 

In picture: researchers of the LU KPMI Signe Mežinska, Daiga Šantare and researcher of Latvian Biomedical Research and Study Centre Vita Rovīte at the stand report

The project “Ethically and socially responsible governance of research biobanks in Latvia: analysis of opinions of public, donors and researchers” is funded by the Latvian Council of Science, project number lzp-2018 / 2-0171.

October 4th, 2019

UNESCO Week 2019 will take place in Riga. Bright Minds: Women in Scienc

From October 14 to 20, UNESCO Week 2019 will take place in Riga, inviting everyone to raise public awareness of the important womens in science and scientist dynasties of Latvia and the contribution of their research to the history of their region, school, institution, museum over a hundred years.
 
The main thematic event "With the inspiration for science" of UNESCO Week 2019 "Bright Minds: Women in Science" will be held on October 16 at 11.00 am, at the University of Latvia Library, 4 Kalpaka Boulevard, Riga and live on the University of Latvia portal: http://www.lu.lv/tiesraide/.

Institute of Clinical and Preventive Medicine of the University of Latvia  will be represented at the event by Signe Mežinska, Associate Professor of the University of Latvia and Latvian representative to the UNESCO International Bioethics Commission. Asoc.Prof. S.Mežinska at the event will report on project "Ethically and socially responsible governance of research biobanks in Latvia: analysis of opinions of public, donors and researchers". 

(The project is carried out within the framework of FLPP (Fundamental and Applied Research Projects) Programm in Latvia, project nr. lzp-2018/2-0171 "Ethically and socially responsible governance of research biobanks in Latvia: analysis of opinions of public, donors and researchers").

More information HERE.

See also on Facebook:

https://www.facebook.com/events/2324009961149641/permalink/2329058700644767/

https://www.facebook.com/events/2324009961149641/

October 3rd, 2019

European experts gathered in Riga to look at the results of the GISTAR study

Today one of the most important events of the GISTAR study this year tooks place at the Academic centre of the University of Latvia - European experts (gastroenterologists, pathologists, epidemiologists, basic science representatives) who agreed to participate in the GISTAR Study Data Safety and Monitoring Board (DSMB) gathered in Riga to critically look at the results of the study, their compliance with the requirements of a wide range of world-class epidemiological studies.

Researchers of the Institute of Clinical and Preventive Medicine of the University of Latvia working together with many international organizations, incl. Healthy Stomach Initiative and the International Agency for Research on Cancer (IARC) has made it possible to carry out a study on the prevention of digestive diseases GISTAR, with support of the Latvian Ministry of Health. So far the study has been carried out in Cesis, Aluksne, Ludza, Dobele, Saldus, Tukums, Madona and Rezekne, from September this year the project is launched in Jekabpils.

The GISTAR study is partly funded by the ERDF (European Regional Development Fund) 1.1.1.1. project "Practical Studies", 2nd phase, project ID Nr. 1.1.1.1/18/A/184 "Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention" and FLPP (Fundamental and Applied Research Projects) within the framework of the Latvian Program, project no. lzp-2018 / 1-0135 "Study on the implementation of a set of measures to prevent gastric cancer mortality by eradicating H.pylori infection and timely detection of gastric pre-cancer conditions".

September 27th, 2019

GISTAR Jekabpils Regional Center is officialy opened

The GISTAR Regional Center for Digestive Disease Prevention Study GISTAR was officially opened today at Jekabpils Regional Hospital, Stadiona Street 1.
In cooperation with Jekabpils Regional Hospital, GISTAR Regional Center for Digestive Disease Prevention Research carried out by LU KPMI started work in Jekabpils on 2 September this year.

The regional center has successfully completed its first month of work, with over 130 respondents. In total, more than 8,450 respondents have already been included in the survey.

Opening attended Members of the board of Jekabpils Regional Hospital - Margarita Melnikova, Renārs Putniņš, professor of the University of Latvia, director of the Institute of Clinical and Preventive Medicine of the University of Latvia, gastroenterologist Marcis Leja, GISTAR research staff, and Kristine Ozola, deputy chairman of Jekabpils City Council.

Currently in Jekabpils the study is planned till the end of 2020, however, in case of higher activity of the population, the possibility to continue its implementation will be evaluated.

 

The GISTAR study is partly funded by the ERDF (European Regional Development Fund) 1.1.1.1. project "Practical Studies", 2nd phase, project ID Nr. 1.1.1.1/18/A/184 "Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention" and FLPP (Fundamental and Applied Research Projects) within the framework of the Latvian Program, project no. lzp-2018 / 1-0135 "Study on the implementation of a set of measures to prevent gastric cancer mortality by eradicating H.pylori infection and timely detection of gastric pre-cancer conditions".

September 26th, 2019

Mission-based science is debated in Brussels

On September 24-26 the Science and Innovation (R&I) Day is takeing place in Brussels, although Latvia is not well represented. During these days, the European Commission (EC) also officially launched a new form of action - mission-based science, already known in other parts of the world, but first introduced at European Union level.

According to Jean Eric Paquet, Director General of R&I, missions are not just science, but their mission is to bring science into a way that is understandable, usable and recognizable to the public. Leading experts from the EC also understand that missions for Europe are not only a completely new form of operation, but also a difficult and potential form of risk.
A total of five missions have been set up to address the EC's identified hot topics - Clean Cities, Clean Oceans, Clean Environment and Nutrition, Adaptation to Climate Change and the Cancer Mission. The latter is represented by Professor Marcis Leja, Director of the Institute of Clinical and Preventive Medicine, University of Latvia.
On September 25, on Mission and Science Day representatives met with organizations and practitioners interested in the field. The cooperation of missions with representatives of both the EC and EU Member States will be essential. Recommendations for mission strategy papers can still be submitted electronically by October 4th.

 
In the first picture (from left): Carlos Moedas, Commissioner for Science and Innovation, Marianna Mazzucato, Mission Theory Expert, and Jean Eric Paquet, Director General of R&I
In the second picture: Jean Eric Paquet gives a start to the mission

September 25th, 2019

Responsible research in clinical research is discussed at the seminars

On September 24 - 27 seminars on responsible research in clinical trials are organized by partners of the Horizon 2020 project A-PATCH - Autonomous Patch for Real-Time Detection of Infectious Disease and VOGAS - Screening of Gastric Cancer via Breath volatile organic compunds by Hybrid Sensing Approach. The partners discussed various aspects of the applicability of the new diagnostic approach, interviewed physicians and nurses to find out how healthcare professionals experience similar systems, and analyzed best practices for obtaining information from potential users worldwide. The seminar are organized by project partners - LU KPMI in collaboration with VTT (Technical Research Center of Finland), with participation of Technion (Israel Institute of Technology), BioRad Laboratories (France) and TNO, HOLST Center (Netherlands), National cancer Institute (Ukraine).

 

The A-PATCH project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824270

The VOGAS project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824986 

September 20th, 2019

Call for applications for Horizon Europe Advisory Expert thematic working groups by September 30

The Ministry of Education and Science, in order to prepare and ensure the representation of Latvian research interests in the development of the EU Horizon Europe 2021-2027 research and innovation program, invites to apply for 5 thematic national consultative expert working groups, as well September 30th by completing the electronic survey form.
Those who have already completed the survey are invited to indicate the partnerships that are in their best interest.
At the same time, in the context of the ongoing strategic planning of the new EU Horizon Europe 2021-2027 research and innovation program, the European Commission invites all interested parties to participate in this process and to complete a survey on research priorities by 6 November.
In addition, please be informed that current information on Horizon Europe is also available in the Science / News / Horizon Europe 2021-2027 section of the Education and Science homepage.
 and on the official website of the European Commission.

September 19th, 2019

Discuss current and future cooperation between LU KPMI and Kazakhstan's scientific institutions

On September 19th at the capital of Kazakhstan Nursultan, doctoral student of LU KPMI Linda Mežmale had a meeting with Professor Nurbek Igissinov, MD, PhD (Doctor of Oncology, Public Health Specialist; Professor of the Department of Surgical Diseases of Internship Department of Astana Medical University; Chairman of the Central Asian Cancer Institute) and discussed current and future cooperation between LU KPMI and Kazakhstan scientific institutions.

September 12th, 2019

The poster emphasizes the importance of subtyping gastric intestinal metaplasia

The 31st Congress of European Pathologists was held September 7 - 11 in Nice, France.

A young scientist Selga Savčenko at the congress presented a report entitled "The value of intestinal metaplasia for the risk stratification of gastric cancer".

The poster emphasized the importance of subtyping of the gastric intestinal metaplasia (IM), which is not currently routine. This is supported by research evidence that up to 30% of high-risk patients may not be identified if IM subtyping is not performed. Because a large proportion of patients with OLGIM I have incomplete IM, which is already a high-risk patient. In contrast, OLGIM I and II are considered low-risk patients and should not be monitored as high-risk.
In addition to the conventional staining method (H&E), AB-PAS and HID are used to identify subtypes of intestinal metaplasia.

Almost 3,900 participants from 92 countries attended the congress.

September 11th, 2019

The results of the GISTAR and VOGAS projects  are demonstrated at the international conference

The 11th International ICAPS conference: Cancer Prevention by Targeting Infection, Inflammation and the Immune System was was taking place in London, UK, on September 9-10.
Scientific leader of GISTAR and VOGAS projects M.Leja was participating with an inivited lecture entitled “H. pylori Eradication for Gastric Cancer Prevention”.
The design of the GISTAR project and preliminary results, as well as results of the Sniffphone/VOGAS survey of specialists were demonstrated during the presentation.
Conference is organized by The International Cancer Prevention Society (ICAPS) and the UK Therapeutic Cancer Prevention Network (UKTCPN).

The GISTAR project has received funding from ERDF (European Regional Development Fund ) within the framework of 2nd part of measure 1.1.1.1. "Practical Studies", project ID Nr. 1.1.1.1/18/A/184 "Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention"

The VOGAS project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824986 .

September 9th, 2019

The results of the VOGAS project are presented at the Breath Summit 2019

The Breath Summit 2019 tooks place in UK, Loughborough, September 8-11, 2019. The VOGAS project is represented by a poster presentation (the first author Inese Poļaka) on the reproducibility of breath testing results and the impact of bfood consumption.


The project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824986 .

September 8th, 2019

EHMSG XXXI International Congress is attended by representatives from LU KPMI

At the European Helicobacter and Microbiota Study Group XXXIIst International Workshop, which took place in Innsbruck, Austria, from 5 to 7 September, scientists from the LU KPMI participated both with poster and oral presentations.

Our team of researchers presented 5 poster and 2 oral presentations.

The conference was attended by JeLizaveta Aleksejeva, Olga Sjomina, Sabine Skrebinska and Reinis Vangravs, residents and graduates of the University of Latvia involved in the scientific work of LU KPMI.

The results of the GISTAR study, VOGAS study and other researches carried out by the institute were reported in the form of stand and oral reports.

Read more.

   

The GISTAR project has received funding from ERDF (European Regional Development Fund ) within the framework of 2nd part of measure 1.1.1.1. "Practical Studies", project ID Nr. 1.1.1.1/18/A/184 "Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention"

The VOGAS project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824986 .

September 6th, 2019

Among the most downloaded articles from HELICOBACTER in 2019 - articles of our researchers

Annual Report 2018 of HELICOBACTER Magazine is published (WILLEY Publishing Company) . The magazine is one of the world's leading publications (IF = 3.52).

The University of Latvia ranks third in the list of institutions whose authors have had the highest impact in 2018, following the Seoul National University in Korea and Ghent University in Belgium.

In 2019 (up to date), among the most downloaded articles -  article by Olga Sjomina ranked second place, a researcher at the Institute of Clinical and Prophylactic Medicine at the University of Latvia, while Sabīne's Skrebinska's - ranked 5th (both first authors).

Congratulations to the researchers for this high score!

September 3rd, 2019

At the European Mission Board for Cancer Latvia will be represented by Director of KPMI Marcis Leja

Today, the European Mission Board for Cancer gathered for its first meeting in Brussels. A total of five mission boards (other EU priorities: Clean Cities, Clean Oceans, Clean Environment and Nutrition, Adaptation to Climate Change) have been set up under the new EU Horizon Europe program to translate scientific excellence into practice and translate it into a language understandable to the public. So in the field of medicine and health, Mission Board for Cancer is the only one that has received such EC support.
The Board is chaired by Harald zur Hausen, a 2008 Nobel laureate in physiology and medicine, whose family roots are in Riga. The Board has a total of 15 members, selected from more than 350 applications. Latvia will be represented in the Council by Marcis Leja, Estonia by Andres Metspalu, the head of the biobank and the creator of the genome center; The Council also includes several representatives of Scandinavian countries, incl. representatives of patient organizations and the new director of the International Agency for Research on Cancer (IARC), Elisabeth Weiderpass.

 

In the pictures: Director of LU KPMI M.Leja                         

In the front view: Director of DG R&I  Kurt Vandenberghe

September 2nd, 2019

The GISTAR Jekabpils Regional Center is launched

In cooperation with Jekabpils Regional Hospital, the GISTAR (largest study of LU KPMI) Regional center in Jekabpils has started its work. On its first working day the center was visited by the first three respondents. In total, 8 319 respondents have already been included in the study.

The project has received funding from ERDF (European Regional Development Fund ) within the framework of 2nd part of measure 1.1.1.1. "Practical Studies", project ID Nr. 1.1.1.1/18/A/184 "Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention"

August 29th, 2019

LU KPMI scientists obtain doctoral positions in speciality of medicine 

The University of Latvia held a competition for budget doctoral positions in medicine.
The competition was successfully attended by KPMI scientists - Linda Mežmale (topic related to the use of volatile marker diagnostics for gastric cancer screening) and Inga Bogdanova (topic related to specialized morphological examination methods for detection of gastric pre-cancerous conditions).

Congratulations and good luck!

August 13th, 2019

Training for employees of Jekabpils Regional Center of GISTAR study

Today at the Academic Centre of the University of Latvia the future employees of the regional GISTAR centre in Jekabpils are undergoing tuition. Scientific leader of the GISTAR study professor Mārcis Leja introduces new employees with the relevance of gastrointestinal cancer in Latvia and globally, as well as reports the significance and essential details of the GISTAR study. During the training, the new team is introduced to the research protocol, questionnaire, specifics of interviewing, as well as the GISTAR data management system.

During the training courses, the new employees are learning the practical skills necessary for the study, as well as how the participants are included in the study. The work is carried out in pairs, the future employees are undergoing tuition, such as questioning, the input of data into the DVS system, standards of taking blood tests and blood sampling, as well as the carrying out, preparation and storage of saliva tests, and the procedures for performing breath tests. Specific diet questions are also studied.

The launch of GISTAR study at Jekabpils regional hospital is scheduled for September this year.

  

The project has received funding from ERDF (European Regional Development Fund ) within the framework of 2nd part of measure 1.1.1.1. "Practical Studies", project ID Nr. 1.1.1.1/18/A/184 "Optimisation of H.pylori eradication therapy for population-based gastric cancer prevention"

August 13th, 2019

The Institute of Clinical and Preventive Medicine is moving to new premises

From August 19, the Institute of Clinical and Preventive Medicine will be located in the new premises at 1 Gaiļezera Street.

Welcome!

July 22nd, 2019

Experience has been exchanged within the framework of the VOGAS project 

A senior post-doctoral researcher of the University of Innsbruck Dr. Pawel Mochalski, Head of the Endoscopy department of National Cancer institute of Ukraine MD Irina Razumeiko  and Clinical Oncologist of the Department of minimally invasive and endoscopic surgery, interventional radiology MD Veronika Patsko, came on an experience exchange within the framework of the VOGAS project.
The purpose of the visit of foreign colleagues was shareing of experience and approbation of methods in the process of obtaining volatile organic markers and stomach biomaterials, equipment assembly and use issues, as well as discussion of current issues of the VOGAS project.

LU KPMI staff - researcher Dr. Viktor Velik and senior laboratory technician Marina Alentieva, as well as Ukrainian colleagues MD Veronika Patsko and MD Irina Razumeiko, were trained in the installation and use of volatile organic marker equipment by Dr. Pawel Mochalski.
Also, the laboratory assistant Marina Alenteva together with Ukrainian colleagues conducted a questionnaire of the patient before the operation.
Dr. Pawel Mochalski and Reinis Vangravs, a research assistant at the LU KPMI, discussed the issues of culturing Helicobacter pylori.
LU KPMI Leading Researcher Dr.med. Sergey Isayev showed Ukrainian colleagues how to take biomaterial for research, as well as told about the pre-cancerous state of the stomach and the histopathology of the tumor.

During the visit gastroenterologist, gastrointestinal endoscopy specialist Dr.med. Ilze Kikuste demonstrated the gastric juice collection and gastric tissue biopsy procedures used in the study to foreign guests, as well as questions about entering patient and examination data into the Biobank electronic system.

At the end of the visit, a tour of the Academic Center of the University of Latvia was organized for the guests, and the LU KPMI laboratories and Biobank premises in the Nature House were shown.

More pictures: Picture_1, Picture_2, Picture_3, Picture_4

The project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824986 .

July 17th, 2019

Pawel Mochalski delivers a presentation on breath analysis

Today Pawel Mochalski (Innsbruck University) is delivering a presentation on breath analysis to physicians and endoscopy nurses in Digestive Diseases Centre GASTRO (Riga, Latvia), the strategic partner for University of Latvia. GASTRO is the leading endoscopy and gastroenterology expert in Latvia, and this is planned that patients being referred for endoscopy to this centre will be recruited to the VOGAS project. Furthermore, GASTRO is going to share its expertise in endoscopy-related issues in research.


More pictures: Picture_1

The project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824986 .

July 16th, 2019

Latest news from the European Society of  Digestive Oncology

Welcome to the latest news from European Society of Digestive Oncology:

 ESDO Members Letter June 2019

 ESDO Members Letter July 2019

July 15th, 2019

Released "Healthy Stomach Initiative" Newsletter 01/2019 

Read the latest news from the Healthy Stomach Initiative" Newsletter 01/2019 HERE.

July 5th, 2019

Working, planning and reporting meetings of the H2020 PITBUL project partners

LU KPMI researcher Ģirts Šķenders from 29.06. until 03.07 participated in the partner working and planning meeting of the Horizon H2020 project PITBUL (“Point-of-care Implementation of TB testing with Ultra-Fast Local heating PCR”) and at the European Society of Mycobacteriology (Valencia, Spain).
At the meeting G. Šķenders gave a presentation "Insights into the clinical workflow. Clinical samples".
From 03.07. until 05.07 Mr. Šķenders participated in the PITBUL Project Partner Reporting Meeting in Brussels, Belgium, at the European Commission, DG Research & Innovation.

    

The project leading to this application has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 768889.

July 4th, 2019

KPMI representatives visit the Horizon 2020 Open Info Day

The Horizon 2020 'Health, demographic change and wellbeing' Open Info Day is going on in Brussels, linked to the opening of the last H2020 project competition. KPMI is also represented at the event, when planning future project applications.

Copyright 2016 - 2020 by LU KPMI